Brief: Kiniksa Announces Issuance Of U.S. Patent For Treatment Of Recurrent Pericarditis
June 8 (Reuters) - Kiniksa Pharmaceuticals Ltd KNSA.O :
* KINIKSA ANNOUNCES ISSUANCE OF U.S. PATENT FOR TREATMENT OF
RECURRENT PERICARDITIS
* KINIKSA PHARMACEUTICALS - U.S PTO ISSUED A PATENT COVERING
METHODS OF USING ARCALYST IN TREATMENT OF RECURRENT PERICARDITIS
Source text for Eikon: ID:nGNX8JG3jR
Further company coverage: KNSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiniksa Pharmaceuticals International
See all newsKiniksa Pharmaceuticals International, PLC reports results for the quarter ended June 30 - Earnings Summary
Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a share - Earnings Preview
Cardiovascular drugmaker Kiniksa's Q1 net income rises
Kiniksa Q4 revenue rises on ARCALYST sales